ClinConnect ClinConnect Logo
Search / Trial NCT07052461

Association of Microcirculation, Vexus Score and Femoral Vein Doppler in Patients on the ICU After Non-emergency Cardiac Surgery

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jun 26, 2025

Trial Information

Current as of July 12, 2025

Not yet recruiting

Keywords

Vexus Score Femoral Vein Doppler Intensive Care Unit

ClinConnect Summary

This clinical trial is looking at how blood flow in tiny vessels (called microcirculation) and signs of swelling in veins might be connected in patients who have had planned (non-emergency) heart surgery. The study aims to understand if pressure or congestion in the veins after surgery affects how well blood moves through small vessels, which is important for healing and recovery in the intensive care unit (ICU).

Adults aged 18 and older who are having planned or urgent heart surgery may be eligible to take part, but people with emergency surgeries, severe kidney problems, or certain liver issues cannot join. If you participate, doctors will use special ultrasound tests to check blood flow and vein health after your surgery while you are in the ICU. This information could help improve care and fluid management for future heart surgery patients. The study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Elective or urgent (need for definitive procedure during hospitalisation, but not emergency intervention) cardiac surgery
  • Exclusion Criteria:
  • Age \< 18 years
  • Pregnant women
  • Known severe chronic kidney disease (estimated glomerular filtration rate \<15 mL/min per 1.73 m2 or dialysis)
  • Renal or liver transplantation
  • Any known condition interfering with Doppler evaluation of the portal system (including known or suspected cirrhosis or portal vein thrombosis or huge abdominal emphysema).
  • Inability to consent to study
  • Emergency cardiac surgery

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, , Switzerland

Patients applied

0 patients applied

Trial Officials

Martin Siegemund, Prof. MD

Study Chair

University Hospital of Basel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported